November 10, 2025 a 11:43 am
AMGN: Fundamental Ratio Analysis - Amgen Inc.
Amgen Inc. is a leading biotechnology company focusing on human therapeutics. With strong partnerships and products in various therapeutic areas, Amgen shows a stable outlook through its innovative drug portfolio. However, investors should consider market dynamics since the sector remains competitive.
Fundamentals Rating
Amgen holds a solid B+ fundamental rating with competitive scores indicating a healthy financial standing. Below are the assessment categories and associated scores:
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
The historical performance indicates consistent scores. Below are the scores from previous and current evaluations:
| Date | Overall | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-11-07 | 3 | 5 | 5 | 5 | 1 | 2 | 1 |
| N/A | 0 | 5 | 5 | 5 | 1 | 2 | 1 |
Analyst Price Targets
Analyst projections suggest stability with a range from low to high estimates. Below are the current estimates:
| High | Low | Median | Consensus |
|---|---|---|---|
| $342 | $300 | $315 | $319 |
Analyst Sentiment
Analyst sentiment is favorable, predominantly suggesting 'Buy'. Here’s the breakdown:
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 22 | |
| Hold | 11 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Amgen Inc. displays robust fundamentals with a positive outlook in the biotechnology sector. Despite its high debt-to-equity ratio, its strong revenue from various products points to growth potential. Analysts show a predominant 'Buy' consensus, reflecting confidence in the stock's future performance. However, investors should remain aware of industry competition and other market dynamics while considering this stock.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years